COMMUNIQUÉS West-GlobeNewswire

-
Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children
12/06/2025 -
Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNH
12/06/2025 -
Significant efficacy benefit of IMBRUVICA® (ibrutinib) plus venetoclax versus acalabrutinib plus venetoclax in frontline treatment of patients with chronic lymphocytic leukaemia suggested by indirect treatment comparison
12/06/2025 -
Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hematology Association 2025 Congress in June
12/06/2025 -
Clariane finalise le plan de renforcement de sa structure financière avec la cession son réseau d’aide à domicile Petits-fils
12/06/2025 -
Clariane completes its plan to strengthen its financial structure with the disposal of its Petits-fils home care services network
12/06/2025 -
Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma
12/06/2025 -
Levicept to Present Further Analysis from Phase II Trial of Novel Neurotrophin-3 Inhibitor, LEVI-04, at EULAR
12/06/2025 -
Mesoblast Maintains Momentum With FDA on Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure and Label Extension for Ryoncil® in Adults With GvHD
12/06/2025 -
Nusano Announces Breakthrough HALEU Program Expected to Produce Up to 350 Metric Tons of Fuel Annually for Advanced Nuclear Reactors
12/06/2025 -
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
12/06/2025 -
SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide
11/06/2025 -
BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG
11/06/2025 -
Abivax Announces Results of its June 6, 2025 Annual General Meeting
11/06/2025 -
Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors
11/06/2025 -
SRx Health Solutions Announces Management and Board Changes
11/06/2025 -
Allarity Therapeutics Announces Changes to Board of Directors
11/06/2025 -
Fortrea Names Anshul Thakral Chief Executive Officer
11/06/2025 -
AIM ImmunoTech Announces 1-for-100 Reverse Stock Split
11/06/2025
Pages